health New advanced leukemia drug leads to ‘impressive’ responses [ad_1] Revumenib, an Investigational Menin Inhibitor, Shows Encouraging Responses in Relapsed or Refractory Patients KMT2A-rearranged or MNP1-mutant acute… bynewsdeskMarch 20, 2023
